2nd February 2018, Volume 131 Number 1469

Romosozumab or alendronate for fracture prevention in women with osteoporosis Romosozumab is a monoclonal antibody that binds to and inhibits sclerostin, increases bone formation and decreases bone resorption. Over 4,000…

Subscriber content

The full contents of this page is only available to subscribers.

To view this content please login or subscribe

Download

The downloadable PDF version of this article is only available to subscribers.

To view this content please login or subscribe